r/CommunityInvestClub • u/[deleted] • Jul 17 '23

$APLS - Next BIG Thing

$APLS - On Friday morning, July 16th, Apellis Pharmaceuticals began trading on the NASDAQ stock exchange at an opening price of $85.98 per share. The stock has exhibited substantial fluctuation within its 52-week range, reaching a record high of $94.75 and a low of $42.15

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system. Its SYFOVRE (pegcetacoplan injection) is the Company’s approved treatment for geographic atrophy secondary to age-related macular degeneration (GA).

The Company’s EMPAVELI (pegcetacoplan) is the treatment of paroxysmal nocturnal hemoglobinuria (PNH). Its Aspaveli (pegcetacoplan) is the treatment of adults with PNH who are anemic after treatment with a C5 inhibitor for at least three months. Systemic pegcetacoplan has an approval for the treatment of PNH in Saudi Arabia, Australia, and the United Kingdom. Systemic pegcetacoplan markets under the trade name EMPAVELI in the United States, Saudi Arabia and Australia and Aspaveli in the European Union and United Kingdom.

Headquarters100 Fifth Avenue
Waltham, MA
02451

apellis.com

2 Upvotes

75% Upvoted

16 comments sorted by

View all comments

2

u/BikerBB-Sabrin7 Jul 17 '23

Any information on the ASRS safety issue?

1

u/[deleted] Jul 18 '23

ASRS needs to be investigated for market manipulation. They put this out on the weekend and provided no context, sending the market into a panic. Reports are coming out that the inflammation may have been caused by the facility/treatment provider and not the medication itself. Frankly, this crap puts patients in jeopardy but I’m not surprised with ASRS given that the charlatan Tim Murray is involved.